Power player; placebo predictors
The MacArthur Foundation honors neuroscientist Beth Stevens, and researchers pin down factors that influence the placebo effect in autism trials.
The MacArthur Foundation honors neuroscientist Beth Stevens, and researchers pin down factors that influence the placebo effect in autism trials.
A $13 million grant from the National Institutes of Health aims to help to make stem cell models of autism, and the ‘unaffected sibling’ of a girl with autism pledges to advance the field.
A $28 million initiative aims to develop objective tools for tracking social skills in children with autism. The initiative’s leader outlines its approach.
The debate over whether to screen all toddlers for autism rages on, and a team of ethicists thinks editing the genomes of human embryos is okay.
Clinical trials of autism treatments are fertile ground for the placebo effect. Bryan King explains how the field must move forward to better evaluate treatments.
Researchers are creating guidelines that would help doctors choose and customize autism treatments.
Scientists should slow down and return to the basic tenets of research to regain the public’s trust.
Translating autism interventions for different cultures is a tricky task. One success story is the Program for the Education and Enrichment of Relational Skills, which has reached at least 20 countries in a dozen languages.
Springer pulled 64 studies over faked peer reviews, and positive clinical trial results are hard to find.
Ethicists need to “get out of the way” of CRISPR, and researchers rally around routine screening for autism.